• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病使女性罹患结直肠癌的风险低于男性。

Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

机构信息

Department of Medicine, Karolinska Institutet, Stockholm Söder Hospital, Stockholm, Sweden.

出版信息

Gastroenterology. 2010 May;138(5):1697-703. doi: 10.1053/j.gastro.2010.02.007. Epub 2010 Feb 16.

DOI:10.1053/j.gastro.2010.02.007
PMID:20167217
Abstract

BACKGROUND & AIMS: Reported differences in cancer risk between male and female animals after chronic inflammation suggest that estrogen has inflammation-modifying properties. Little is known about these effects in human beings. Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC); we studied differences in inflammation-associated CRC between men and women patients with IBD.

METHODS

By using a large population-based cohort (n = 7607) of individuals diagnosed with IBD from 1954 to 1989, we assessed the sex-specific incidence of CRC from 1960 to 2004. Incidence was determined within the cohort (modeled using Poisson regression) and compared with the general population (assessed as standardized incidence ratios) using data from national Swedish health and census registers.

RESULTS

During 171,000 person-years of follow-up evaluation, 196 new cases of CRC were observed (123 in males, 73 in females). Males with IBD had a 60% higher risk of CRC (relative risk [RR], 1.6; 95% confidence interval [CI], 1.2-2.2) than females (cumulative incidence 40 years after IBD diagnosis, 8.3% vs 3.5%). Compared with the rate of CRC among the general population, in males with IBD the RR was 2.6 and the 95% CI was 2.2-3.1, whereas in females the RR was 1.9 and the 95% CI was 1.5-2.4. The effect of sex was limited to the period after 10 years of follow-up evaluation (RR, 0.8 before vs 2.2 after), and to patients diagnosed before age 45 (RR, 2.1 before vs 1.0 after).

CONCLUSIONS

IBD confers a lower risk of CRC to females than to males.

摘要

背景与目的

据报道,慢性炎症后雄性和雌性动物的癌症风险存在差异,这表明雌激素具有炎症调节作用。目前人们对人类的这些影响知之甚少。炎症性肠病(IBD)与结直肠癌(CRC)的风险增加有关;我们研究了 IBD 患者中与炎症相关的 CRC 在男性和女性之间的差异。

方法

通过使用一个大型基于人群的队列(n=7607),我们评估了 1954 年至 1989 年期间诊断为 IBD 的个体从 1960 年至 2004 年 CRC 的特定性别发病率。使用 Poisson 回归模型在队列内确定发病率(模型),并使用来自国家瑞典健康和人口普查登记处的数据,将发病率与普通人群(评估为标准化发病率比)进行比较。

结果

在 171000 人年的随访评估期间,观察到 196 例新的 CRC 病例(男性 123 例,女性 73 例)。IBD 男性患 CRC 的风险比女性高 60%(相对风险 [RR],1.6;95%置信区间 [CI],1.2-2.2)(40 年后 IBD 诊断的累积发病率,男性为 8.3%,女性为 3.5%)。与普通人群的 CRC 发生率相比,IBD 男性的 RR 为 2.6,95%CI 为 2.2-3.1,而女性的 RR 为 1.9,95%CI 为 1.5-2.4。这种性别差异仅限于随访评估 10 年后的时期(RR,0.8 年前 vs 2.2 年后),以及诊断年龄小于 45 岁的患者(RR,2.1 年前 vs 1.0 年后)。

结论

IBD 对女性 CRC 的风险低于男性。

相似文献

1
Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.炎症性肠病使女性罹患结直肠癌的风险低于男性。
Gastroenterology. 2010 May;138(5):1697-703. doi: 10.1053/j.gastro.2010.02.007. Epub 2010 Feb 16.
2
Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.30 余年来炎症性肠病患者结直肠癌发病风险降低。
Gastroenterology. 2012 Aug;143(2):375-81.e1; quiz e13-4. doi: 10.1053/j.gastro.2012.04.016. Epub 2012 Apr 19.
3
Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.炎症性肠病患者队列中临床参数与结直肠癌-结肠炎间隔时间的关系
Scand J Gastroenterol. 2009;44(1):46-55. doi: 10.1080/00365520801977568.
4
5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.5-氨基水杨酸对炎症性肠病患者的结直肠癌不具有化学预防作用:一项基于人群的研究。
Am J Gastroenterol. 2011 Apr;106(4):731-6. doi: 10.1038/ajg.2011.50. Epub 2011 Mar 15.
5
Risk factors of colorectal cancer in inflammatory bowel disease.炎症性肠病中结直肠癌的危险因素。
Am J Gastroenterol. 1996 Jan;91(1):44-8.
6
The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.炎症性肠病中动脉血栓栓塞性疾病的发病率:一项基于人群的研究。
Clin Gastroenterol Hepatol. 2008 Jan;6(1):41-5. doi: 10.1016/j.cgh.2007.09.016. Epub 2007 Dec 11.
7
Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎肝移植术后炎症性肠病患者的结直肠癌
Transplantation. 2003 Jun 27;75(12):1983-8. doi: 10.1097/01.TP.0000058744.34965.38.
8
Colorectal cancer prognosis among patients with inflammatory bowel disease.炎症性肠病患者的结直肠癌预后
Clin Gastroenterol Hepatol. 2006 Mar;4(3):335-42. doi: 10.1016/j.cgh.2005.12.035.
9
Chemoprevention for colon cancer: new opportunities, fact or fiction?结肠癌的化学预防:新机遇,事实还是虚构?
Scand J Gastroenterol Suppl. 2006(243):158-64. doi: 10.1080/00365520600664284.
10
Long-term use of statins and risk of colorectal cancer: a population-based study.长期使用他汀类药物与结直肠癌风险:一项基于人群的研究。
Am J Gastroenterol. 2009 Dec;104(12):3015-23. doi: 10.1038/ajg.2009.574. Epub 2009 Oct 6.

引用本文的文献

1
Exploration of JAK/STAT pathway activation in ulcerative colitis reveals sex-dependent activation of JAK2/STAT3 in the inflammatory response.溃疡性结肠炎中JAK/STAT信号通路激活的研究揭示了炎症反应中JAK2/STAT3的性别依赖性激活。
Front Immunol. 2025 Jul 21;16:1609740. doi: 10.3389/fimmu.2025.1609740. eCollection 2025.
2
Trends and disparities in inflammatory bowel disease and cardiovascular disease-related mortality in the United States from 1999 to 2023: A CDC WONDER analysis.1999年至2023年美国炎症性肠病和心血管疾病相关死亡率的趋势与差异:疾病控制与预防中心的WONDER分析
Int J Cardiol Cardiovasc Risk Prev. 2025 May 22;26:200438. doi: 10.1016/j.ijcrp.2025.200438. eCollection 2025 Sep.
3
Influence of biological sex in inflammatory bowel diseases.
生物性别对炎症性肠病的影响。
Nat Rev Gastroenterol Hepatol. 2025 Feb 17. doi: 10.1038/s41575-025-01038-y.
4
Spatial profiling of the mouse colonic immune landscape associated with colitis and sex.与结肠炎和性别相关的小鼠结肠免疫景观的空间分析。
Commun Biol. 2024 Nov 29;7(1):1595. doi: 10.1038/s42003-024-07276-1.
5
MAD1 upregulation sensitizes to inflammation-mediated tumor formation.MAD1 上调使肿瘤对炎症介导的形成敏感。
PLoS Genet. 2024 Oct 7;20(10):e1011437. doi: 10.1371/journal.pgen.1011437. eCollection 2024 Oct.
6
Inflammatory Bowel Disease and Colorectal Cancer.炎症性肠病与结直肠癌
Cancers (Basel). 2024 Aug 23;16(17):2943. doi: 10.3390/cancers16172943.
7
Precision medicine in inflammatory bowel disease.炎症性肠病中的精准医学。
Precis Clin Med. 2023 Dec 18;6(4):pbad033. doi: 10.1093/pcmedi/pbad033. eCollection 2023 Dec.
8
Sex-Based Differences in IBD Surgical Outcomes.基于性别的炎症性肠病手术结局差异。
Dis Colon Rectum. 2024 Feb 1;67(2):246-253. doi: 10.1097/DCR.0000000000002984. Epub 2023 Oct 23.
9
The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease.2023年炎症性肠病对加拿大的影响:性别对加拿大炎症性肠病患者的影响
J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S55-S63. doi: 10.1093/jcag/gwad011. eCollection 2023 Sep.
10
Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management.炎症性肠病与结直肠癌:流行病学、病因学、监测与管理
Cancers (Basel). 2023 Aug 17;15(16):4154. doi: 10.3390/cancers15164154.